Pfizer Predicts Record Profits From COVID Products, Says Chances ‘Very High’ FDA Will Authorize Vaccine for Babies and Toddlers
Pfizer announced Tuesday projected combined sales of its COVID vaccine and antiviral drug Paxlovid should top $54 billion in 2022, but the company’s stock dropped sharply today. By David Charbonneau, Ph.D. Pfizer announced Tuesday projected combined sales of its COVID vaccine and antiviral drug Paxlovid should top…